XENE   $41.16  3.42% Market Closed After Close 43.0 4.47%

Xenon Pharmaceuticals Inc
Total Cash 721.53M
totalCashPerShare 9.523
EBITDA -233.68M
Total Debt 10.03M
quickRatio 23.091
currentRatio 23.273
Total Revenue
debtToEquity 1.189
Revenue/Share
ROA -0.18924
ROE -0.26709998
grossProfits
freeCashflow -104.09M
operatingCashflow -153.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.57B
forwardPE -12.44382
floatShares 69.99M
sharesOutstanding 75.76M
sharesShort 3.16M
sharesShortPriorMonth 3.60M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.01%
Short Ratio help_outline 9.67%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 11.155
Price To Book help_outline 3.97
earningsQuarterlyGrowth
netIncomeToCommon -199.06M
trailingEps -2.73%
forwardEps -3.56%
enterpriseToEbitda -11.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.81 3Q 2024
institutionsCount 293
lastUpdated Nov. 6, 2024, 6:26 p.m.